Pediatric Solid Tumor Program

We provide advanced therapies and personalized care to help children with solid tumors live longer, fuller lives.
Pediatric Solid Tumor Program

On this page

Why choose UCSF Benioff Children's Hospitals for pediatric solid tumor care?

At UCSF Benioff Children's Hospitals, we provide specialized care for children, adolescents and young adults (age 30 and younger) with extracranial solid tumors. These are masses of abnormal cells that occur outside the brain in bones, organs, muscles and other soft tissues.

Solid tumors require a different treatment approach than other childhood cancers. That's why it's so important to seek care from a specialized team with deep expertise in these conditions.

Families from across the Western U.S. come to us for our experience diagnosing and treating solid tumors, including:

We offer innovative therapies and family-focused care to achieve the best possible outcome for each child. If you live far away, we offer virtual follow-up visits and maintain close communication with your local care team, to ensure coordinated care close to home.

Advanced diagnostics for solid tumors

The UCSF500 Cancer Gene Panel is a state-of-the-art test using DNA and RNA sequencing to find genetic changes (mutations) that drive cancer. These insights help us make more precise diagnoses for rare or complex tumors. The results also allow us to plan more effective treatments and potentially match children to emerging therapies in clinical trials.

We are leaders in pharmacogenomics testing, which analyzes a child's blood to find out how they may respond to certain medications, including chemotherapy. This information enables us to select safer, more effective doses while reducing the risk of side effects.

Innovative, personalized therapies

Our team uses advanced technologies and specialized procedures to achieve the best possible outcome for each child:

  • Endoprosthetic reconstruction. For children with bone tumors, pediatric orthopedic surgeons offer expandable implants that grow with children, reducing the need for additional surgeries. We also design custom, 3D-printed prostheses for complex cases.

  • Fluorescence-guided surgery. Surgeons use a fluorescent contrast dye called indocyanine green (ICG) to illuminate hard-to-detect tumors that have spread (metastasized). This helps us remove tumors more precisely.

  • Radionuclide therapies. We are among only a few programs on the West Coast offering MIBG (metaiodobenzylguanidine) therapy for patients with relapsed or treatment-resistant neuroblastoma. This highly targeted treatment slows tumor growth and preserves healthy tissue.

  • Stereotactic body radiation therapy (SBRT). We target tumors with high doses of radiation, reducing treatment time from weeks to days. SBRT can help ease symptoms and improve quality of life for children with metastatic cancer.

Clinical trials for solid tumors

We participate in several leading early-phase clinical trial networks. Through these partnerships, we give children and young adults access to promising new treatments that may not be widely available.

Our participation includes:

  • Children's Oncology Group (COG) Pediatric Early Phase Clinical Trials Network (PEP-CTN), the only core site in Northern California

  • Pacific Pediatric Neuro-Oncology Consortium (PNOC)

  • New Approaches to Neuroblastoma Therapy (NANT) consortium

  • North American Consortium for Histiocytosis (NACHO)

  • Beat Childhood Cancer (BCC) Research Consortium

Providers

Awards & achievements

Recognized nationally for excellence, we pair world-class medical expertise with compassionate care to deliver the best possible outcomes for patients.
1of4
  • 360+

    patients treated with MIBG therapy, a leading-edge neuroblastoma treatment

  • U.S. News & World Report Best Children's Hospitals 2026-2027, cancer

    Best in Northern California and top 10 in the nation for cancer care

  • Designated an early phase clinical trials core site by the Children's Oncology Group

  • U.S. News & World Report Best Children's Hospitals 2026-2027, ranked in 11 specialties

    Ranked among the nation's best in 11 specialties

Icon

Related conditions & treatments

pencil

Trials & research

Research initiatives

Cancer care for adults

When the time is right, we guide young adults to the next phase of cancer care to support their long-term health.